James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Yes, Juno Therapeutics (JUNO) Just Became a Great CAR-T Trade

JUNO stock may look and feel a little overbought right now, but a stake in Juno Therapeutics right now may well be worth the price.

Under Armour (UAA) Spends More, Gets Less

UAA stock may be tempting after 65%, two-year pullback. Until Under Armour fixes this problem though, there's no turnaround on the horizon.

Forget the Bears – Buy FireEye (FEYE) Stock!

FEYE has been a lackluster performer for years now, but take a closer look at where FireEye, and where it's going.

5 Types of Stocks for Your Portfolio’s Midlife Crisis

As you grow older, value matters more and more. Here's a gameplan -- and some specific stocks to buy -- to navigate an ever-changing market.

Don’t Overlook This Part of Apple Inc.’s (AAPL) Latest Victory

AAPL stock may be headed into a selloff despite the debut of its impressive new iPhones, but there's a much bigger victory for Apple in the midst of the buzz.